Meningiomas expressing and responding to cholecystokinin (CCK)

Eftychia Oikonomou, Ana L. Machado, Michael Buchfelder, Eric F. Adams*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The effect of cholecystokinin (CCK) on cultured human meningioma derived cells was investigated. Exposure of meningioma cells for 6-12 days to CCK-8s (2-200 nM) resulted in a dose dependent stimulation of cell growth to a maximum of 1.1-fold over basal controls. A time course study showed stimulation of cell growth at day 3 followed by increase throughout day 6. The stimulatory effect of CCK on meningioma cell growth was completely abolished by a CCK-B specific receptor antagonist, L-365,260. Reverse-transcription of meningioma-derived RNA into cDNA followed by amplification by the polymerase chain reaction using specific primers for CCK peptide and its CCK-A and/B receptor revealed 100% presence of CCK peptide and CCK-B receptors mRNA whereas CCK-A receptor was expressed in 66% of the meningiomas. These results provide evidence that human meningioma cells possess CCK peptide and its receptors the activation of which leads to increase of cell growth possibly via an autocrine/paracrine mechanism. © Springer 2005.

Original languageEnglish
Pages (from-to)199-204
Number of pages6
JournalJournal of Neuro-Oncology
Issue number3
Publication statusPublished - Jul 2005


  • CCK-A and/B antagonist CCK Receptors
  • cholecystokinin
  • epidermal growth factor
  • meningioma


Dive into the research topics of 'Meningiomas expressing and responding to cholecystokinin (CCK)'. Together they form a unique fingerprint.

Cite this